Group One Trading’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Group One Trading’s Portfolio EIDX Stock Details EIDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-4,500	Closed	-$592K	–	8292
2020 Q4	$592K	Buy	4,500 +2,000	+80%	+$177K	﹤0.01%	3127
2020 Q3	$126K	Buy	2,500 +1,600	+178%	+$71.9K	﹤0.01%	4029
2020 Q2	$43K	Sell	900 -1,600	-64%	-$74.4K	﹤0.01%	4462
2020 Q1	$122K	Buy	2,500 +500	+25%	+$25.5K	﹤0.01%	3143
2019 Q4	$115K	Buy	+2,000	New	+$99K	﹤0.01%	3557

Group One Trading's EIDX Position: Q2 2020 in Review

Group One Trading sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q2 2020, closing a stake of 2,035 shares — an estimated $94.6K sold.

Group One Trading first reported a position in EIDX in Q4 2019 and held it in 2 quarters. The position peaked at $100K in Q1 2020. 92 funds tracked by Wall St. Rank hold EIDX as of Q2 2020.

Group One Trading reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Group One Trading sold 2,035 Eidos Therapeutics, Inc. Common Stock shares in Q2 2020, an estimated $94.6K.
Group One Trading first reported a position in Eidos Therapeutics, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
Group One Trading's Eidos Therapeutics, Inc. Common Stock position peaked at $100K in Q1 2020.
92 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q2 2020.

Based on Group One Trading's 13F filing for Q2 2020, filed 13 Aug 2020.